Latest by SR Hosein

Anti-Cancer Agents: A. Kaposi's Sarcoma -- Past and Future

One of the hallmarks of AIDS, particularly in the early years of the pandemic, was the appearance of skin tumours called Kaposi's sarcoma (KS). During the 1980s, KS was very common in people with AIDS. Indeed, in those years, sometimes the only initi...

By SR Hosein for Canadian AIDS Treatment Information Exchange

Anti-Cancer Agents: B. More About KS

KS is divided into four types depending partly on ethnicity and geography, as follows:

Classic KS

This rare disease tends to occur in men of Mediterranean or Jewish heritage who are 50 years or older. Skin lesions usually appear on the feet or uppe...

By SR Hosein for Canadian AIDS Treatment Information Exchange

Anti-Cancer Agents: C. KS in HIV-Negative Men

Studies in Western Europe and the United States suggest that about 25% of gay men are infected with HHV-8. In contrast, in women and in men who are not MSM, rates of infection are less than 5%.

Researchers at two hospitals in Paris have been studyin...

By SR Hosein for Canadian AIDS Treatment Information Exchange

Anti-Cancer Agents: D. Liposomal Chemo for KS

The use of HAART suppresses HIV production, which allows the immune system to begin repairs. As a result, previously hard-to-treat infections usually begin to respond to therapy and may go into remission.

In HIV positive people with a limited number...

By SR Hosein for Canadian AIDS Treatment Information Exchange

Anti-HIV Agents: A. Good News for HAART Users

In high-income regions such as North America, Western Europe and Australia, highly active antiretroviral therapy (HAART) has been available since about 1996. In these regions, HAART’s impact has been dramatic. For instance, once-dreaded AIDS-related ...

By SR Hosein for Canadian AIDS Treatment Information Exchange